Elan's Panoject Minifusor
This article was originally published in The Gray Sheet
Executive Summary
Two versions of the miniaturized modular infusion pump are granted 510(k) clearance, the Athlone, Ireland-based company announces May 19. Model 100 provides continuous drug delivery therapies while Model 200 is for continuous plus patient controlled analgesia. The ambulatory intravenous or subcutaneous infusion devices utilize Elan's Electro-Transport Drug Administration System (ETDAS) technology ("The Gray Sheet" Jan. 14, 1991, I&W-3) and "can be used for a variety of regimens to include pain management, insulin delivery, chemotherapy, antibiotic, anti-emetic, anticoagulation, tocolytic, AIDS, and chelation therapies," the company says. Since the system will be sold with empty cartridges which will be filled by the pharmacist or physician, FDA approval for use with specific drugs is not necessary. Panoject Minifusor was developed through Elan Medical Technologies Ltd., a joint venture with the Swiss company Pharmasys